University of California, Irvine

  Award Total: $7,053,211 # of Awards: 43 Home Page:

Investigators

  Bogi Andersen , M.D.- Hyeon-Man Baek , Ph.D.- Catherine Blake , M.S.- John Butler , M.D.- John Butler , M.D.- Ralph Delfino , M.D., Ph.D.- Mikhail Geyfman , B.S.- Erin Goldblatt , Ph.D.- Bingnan Gu , Ph.D.- Gultekin Gulsen , Ph.D.- Randall Holcombe , M.D.- Randall Holcombe , M.D.- Nola Hylton , Ph.D.- Peter Kaiser , Ph.D.- Peter Kaiser , Ph.D.- Keon Wook Kang , Ph.D.- Muqing Lin , M.S.- J. Lawrence Marsh , - Sean Merritt , B.S.- Shiraz Mishra , M.B.B.S., Ph.D- Orhan Nalcioglu , Ph.D.- Orhan Nalcioglu , Ph.D.- Edward Nelson , M.D.- Edward Nelson , M.D.- Susan Neuhausen , Ph.D.- Ke Nie , M.S.- Hannah Lui Park , PH.D.- Michael Samoszuk , M.D.- Michael Samoszuk , M.D.- Min-Ying (Lydia) Su , Ph.D.- Min-Ying (Lydia) Su , Ph.D.- Michelle Tabb , Ph.D.- Sora Tanjasiri , DrPH, MPH- Sora Tanjasiri , DrPH, MPH- Heidi Theisen , Ph.D.- Bruce Tromberg , Ph.D.- Bruce Tromberg , Ph.D.- Bruce Tromberg , Ph.D.- Lan Truong , B.S.- Connie Tsai , B.S.- Suman Verma , Ph.D.- Marian Waterman , Ph.D.- Marian Waterman , Ph.D.- Xiaoman Xu , B.S.- Min Yang , M.D.,M.S.- Kyoko Yokomori , Ph.D.- Zhengquan Yu , Ph.D.- Jiewen Zhu , Ph.D.- Argyrios Ziogas , Ph.D.-

Grants

Title[sort] Cycle Award[sort]
Epigenetic markers for pesticide exposure and cancer risk 2016 (Cycle 22) $1,249,970
 Investigator(s): Hannah Lui Park, PH.D. 22UB-2311
MRI Registration for Therapy Evaluation and Annual Screening 2010 (Cycle 16) $76,000
 Investigator(s): Muqing Lin, M.S. 16GB-0056
Hec1 Inhibitor Synergizes With Taxol in Breast Cancer 2010 (Cycle 16) $0
 Investigator(s): Erin Goldblatt, Ph.D. 16FB-0026
The Role of Clim Proteins in Breast Cancer 2010 (Cycle 16) $37,961
 Investigator(s): Suman Verma, Ph.D. 16FB-0028
Inhibitors of Condensin I as Chemotherapy for Breast Cancer 2009 (Cycle 15) $100,000
 Investigator(s): Kyoko Yokomori, Ph.D. 15IB-0089
Regulation of Breast Stem-Progenitor Cell Chromatin by Pygo2 2008 (Cycle 14) $135,000
 Investigator(s): Bingnan Gu, Ph.D. 14FB-0129
Development of a Breast MRI Computer-Aided Diagnosis System 2008 (Cycle 14) $76,000
 Investigator(s): Ke Nie, M.S. 14GB-0148
Role of Estrogen-modulated Protein AGR2 in Breast Cancer 2008 (Cycle 14) $71,491
 Investigator(s): Mikhail Geyfman, B.S. 14GB-0163
The Relationship of BRCA1 and HMGA2 in Breast Cancer 2007 (Cycle 13) $36,704
 Investigator(s): Connie Tsai, B.S. 13GB-0152
Competition for ADA2 and 3 to Inhibit p53 in Breast Cancer 2007 (Cycle 13) $21,574
 Investigator(s): Min Yang, M.D.,M.S. 13GB-0154
In Vivo MRS for Cancer Diagnosis and Treatment Monitoring 2006 (Cycle 12) $90,000
 Investigator(s): Hyeon-Man Baek, Ph.D. 12FB-0031
Combined Imaging Modalities for Breast Cancer 2006 (Cycle 12) $149,162
 Investigator(s): Gultekin Gulsen, Ph.D. 12IB-0095
A Role for p53 and Splicing Factor SAP145 in Breast Cancer 2005 (Cycle 11) $76,000
 Investigator(s): Lan Truong, B.S. 11GB-0104
Inhibition of the BRCA2-RAD51 Interaction in Breast Cancer 2005 (Cycle 11) $134,769
 Investigator(s): Jiewen Zhu, Ph.D. 11FB-0117
Identification of BRCA1 Ubiquitylation Targets 2005 (Cycle 11) $199,600
 Investigator(s): Peter Kaiser, Ph.D. 11NB-0177
Modulation of TGF-beta Signaling in Mammary Epithelial Cells 2005 (Cycle 11) $73,723
 Investigator(s): Xiaoman Xu, B.S. 11GB-0143
The Role of LMO4 in Breast Cancer 2005 (Cycle 11) $135,000
 Investigator(s): Zhengquan Yu, Ph.D. 11FB-0142
Breast Cancer Functional Imaging with Optics and MRI 2004 (Cycle 10) $500,000
 Investigator(s): Bruce Tromberg, Ph.D. 10EB-0208
Breast Cancer Functional Imaging with Optics and MRI 2004 (Cycle 10) $500,000
 Investigator(s): John Butler, M.D. 10EB-0208
Breast Cancer Functional Imaging with Optics and MRI 2004 (Cycle 10) $500,000
 Investigator(s): Nola Hylton, Ph.D. 10EB-0208
Combined Optical and MRI Imaging for Breast Cancer 2003 (Cycle IX) $58,304
 Investigator(s): Sean Merritt, B.S. 9GB-0085
Angiogenesis in Hyperplasia to In-Situ Breast Cancers 2003 (Cycle IX) $250,000
 Investigator(s): Min-Ying (Lydia) Su, Ph.D. 9WB-0020
Identification of BRCA1 Ubiquitylation Targets 2003 (Cycle IX) $75,000
 Investigator(s): Peter Kaiser, Ph.D. 9IB-0124
The IGF Pathway & Breast Cancer Risk in African Americans 2003 (Cycle IX) $422,467
 Investigator(s): Susan Neuhausen, Ph.D. 9PB-0142
Mechanism of Estrogen Receptor Loss in Breast Cancer 2003 (Cycle IX) $17,298
 Investigator(s): Keon Wook Kang, Ph.D. 9FB-0135
Pilot Studies of Breast Cancer Immunophototherapy 2003 (Cycle IX) $99,834
 Investigator(s): Edward Nelson, M.D. 9IB-0119
Using Scientific Text to Identify Breast Cancer Risk-Factors 2002 (Cycle VIII) $29,136
 Investigator(s): Catherine Blake, M.S. 8GB-0175
Clotting Breast Cancer 2002 (Cycle VIII) $98,986
 Investigator(s): Michael Samoszuk, M.D. 8IB-0009
A New Genetic Vaccine Therapy for Breast Cancer 2001 (Cycle VII) $100,000
 Investigator(s): Edward Nelson, M.D. 7WB-0114
A Network-Based Intervention for Chamorros in Southern CA 2001 (Cycle VII) $165,419
 Investigator(s): Sora Tanjasiri, DrPH, MPH 7BB-1901S
Genetic and Environmental Modifiers of Breast Cancer Risk 2000 (Cycle VI) $287,979
 Investigator(s): Argyrios Ziogas, Ph.D. 6PB-0061
Non-Invasive Optical Characterization of Breast Physiology 2000 (Cycle VI) $499,915
 Investigator(s): Bruce Tromberg, Ph.D. 6EB-0123
Non-Invasive Optical Characterization of Breast Physiology 2000 (Cycle VI) $499,915
 Investigator(s): John Butler, M.D. 6EB-0123
Wnt Signaling in Breast Cancer: Translational Studies 2000 (Cycle VI) $328,129
 Investigator(s): Marian Waterman, Ph.D. 6EB-0098
Wnt Signaling in Breast Cancer: Translational Studies 2000 (Cycle VI) $328,129
 Investigator(s): Randall Holcombe, M.D. 6EB-0098
Wnt Signaling in Breast Cancer: Translational Studies 2000 (Cycle VI) $328,129
 Investigator(s): J. Lawrence Marsh, 6EB-0098
Thrombosis for Anti-angiogenic Therapy of Breast Cancer 2000 (Cycle VI) $199,633
 Investigator(s): Min-Ying (Lydia) Su, Ph.D. 6JB-0029
A New Gene Regulation Factor, LMO-4, in Breast Cancer 1999 (Cycle V) $54,823
 Investigator(s): Bogi Andersen, M.D. 5JB-0119A
SXR: A Novel Target for Breast Cancer Therapeutics 1999 (Cycle V) $58,132
 Investigator(s): Michelle Tabb, Ph.D. 5FB-0100
Samoans and Breast Cancer: Evaluating a Theory-Based Program 1998 (Cycle IV) $168,946
 Investigator(s): Shiraz Mishra, M.B.B.S., Ph.D 4BB-1401
Regulation of Wnt: Clues for breast cancer pathognesis 1997 (Cycle III) $13,849
 Investigator(s): Heidi Theisen, Ph.D. 3FB-0090
Breast Cancer Knowledge/Attitudes:So. Cal. Pacific Islanders 1997 (Cycle III) $70,000
 Investigator(s): Sora Tanjasiri, DrPH, MPH 3FB-0166
MRI Detection of Breast Cancer Blood Vessels 1997 (Cycle III) $149,935
 Investigator(s): Orhan Nalcioglu, Ph.D. 3IB-0028
Non-Invasive Optical Detection of Breast Cancer 1996 (Cycle II) $50,000
 Investigator(s): Bruce Tromberg, Ph.D. 2IB-0183
Proper relocation of a tumor suppressor in Breast Cancer 1996 (Cycle II) $50,000
 Investigator(s): Marian Waterman, Ph.D. 2IB-0220
Blocking Breast Cancer Progression with Radioactive Antibody 1995 (Cycle I) $50,000
 Investigator(s): Michael Samoszuk, M.D. 1IB-0219
Investigation of Improved Drug Delivery in Breast Cancer 1995 (Cycle I) $292,905
 Investigator(s): Orhan Nalcioglu, Ph.D. 1RB-0160
Susceptibility to Breast Cancer: Dietary and Other Factors 1995 (Cycle I) $299,567
 Investigator(s): Ralph Delfino, M.D., Ph.D. 1RB-0295